Efficiency of phage cocktails in the inactivation of Vibrio in aquaculture

Aquaculture

Volumn 424-425, Issue , 2014, Pages 167-173

  Mateus, L ^a   Costa, L ^a   Silva, Y J ^a   Pereira, C ^a   Cunha, A ^a   Almeida, A ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

Aquaculture system; Pathogenic bacteria; Phage cocktails; Phage therapy; Vibriosis

Indexed keywords

ANTIBIOTICS; BACTERIOPHAGE; BACTERIUM; COST-BENEFIT ANALYSIS; DISEASE CONTROL; DISEASE RESISTANCE; LYSIS; PATHOLOGY;

EID: 84892859126     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquaculture.2014.01.001     Document Type: Article

References (55)

1. Abedon S.T., Culler R.R. Optimizing bacteriophage plaque fecundity. J. Theor. Biol. 2007, 249:582-592.
2. Adams N.A. Bacteriophages 1959, John Wiley and Sons Inc., New York.
3. Almeida A., Cunha A., Gomes N.C., Alves E., Costa L., Faustino M.A. Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants. Mar. Drugs 2009, 7:268-313.
4. Anonymous Phage therapy. Lancet 1983, 1287-1288.
5. Benediktsdottir E., Helgason S., Sigurjónsdóttir H. Vibrio spp. isolated from salmonids with shallow skin lesions and reared at low temperature. J. Fish Dis. 1998, 21:19-28.
6. Cairns B.J., Timms A.R., Jansen V.A., Connerton I.F., Payne R.J. Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy. PloS Pathog. 2009, 5:1-10.
7. Capparelli R., Nocerino N., Lanzetta R., Silipo A., Amoresano A., Giangrande C., Becker K., Blaiotta G., Evidente A., Cimmino A. Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice. PLoS ONE 2010, 5:1-13.
8. Carlton R.M. Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. 1999, 47:267-274. (English Ed).
9. Chan B.K., Abedon S.T., Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future Microbiol 2013, 8:769-783.
10. Crothers-Stomps C., Høj L., Bourne D., Hall M., Owens L. Isolation of lytic bacteriophage against Vibrio harveyi. J. Appl. Microbiol. 2010, 108:1744-1750.
11. Defoirdt T., Sorgeloos P., Bossier P. Alternatives to antibiotics for the control of bacterial disease in aquaculture. Curr. Opin. Microbiol. 2011, 14:251-258.
12. Essoh C., Blouin Y., Loukou G., Cablanmian A., Lathro S., Kutter E., Thien H., Vergnaud G., Pourcel C. The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages. PLoS ONE 2013, 8:1-12.
13. FAO The State of World Fisheries and Aquaculture-2008 2009, FAO Fisheries and Aquaculture Department, Rome.
14. Filippov A.A., Sergueev K.V., He Y., Huang X.Z., Gnade B.T., Mueller A.J., Fernandez-Prada C.M., Nikolich M.P. Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for mice. PLoS ONE 2011, 6:1-11.
15. Gill J.J., Hyman P. Phage choice, isolation, and preparation for phage therapy. Curr. Pharm. Biotechnol. 2010, 11:2-14.
16. Hanna P., Altmann K., Chen D., Smith A., Cosic S., Moon P., Hammond L. Development of monoclonal antibodies for the rapid identification of epizootic Vibrio species. J. Fish Dis. 1992, 15:63-69.
17. Heller K.J. Molecular interaction between bacteriophage and the gram-negative cell envelope. Arch. Microbiol. 1992, 158:235-248.
18. Higuera G., Bastías R., Tsertsvadze G., Romero J., Espejo R.T. Recently discovered Vibrio anguillarum phages can protect against experimentally induced vibriosis in Atlantic salmon, Salmo salar. Aquaculture 2013, 392-395:128-133.
19. Karunasagar I., Shivu M.M., Girisha S.K., Krohne G., Karunasagar I. Biocontrol of pathogens in shrimp hatcheries using bacteriophages. Aquaculture 2007, 268:288-292.
20. Kaysner C., DePaola A. Outbreaks of Vibrio parahaemolyticus gastroenteritis from raw oyster consumption: assessing the risk of consumption and genetic methods for detection of pathogenic strains. J. Shellfish Res. 2000, 19:657.
21. Kunisaki H., Tanji Y. Intercrossing of phage genomes in a phage cocktail and stable coexistence with Escherichia coli 0157:H7 in anaerobic continuous culture. Appl. Microbiol. Biotechnol. 2010, 85:1533-1540.
22. Labrie S.J., Samson J.E., Moineau S. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 2010, 8:317-327.
23. Levin B.R., Bull J.J. Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2004, 2:166-173.
24. Liston J. Microbial hazards of seafood consumption. Food Technol. 1990, 44:56-62.
25. Louvado A., Coelho F.J.R.C., Domingues P., Gomes N.C.M., Santos A.L., Almeida A., Cunha A. Isolation of surfactant-resistant pseudomonads from the estuarine surface microlayer. J. Microbiol. Biotechnol. 2012, 22(3):283-291.
26. Martinez J.L. Recent Advances in Marine Biotechnology. Molecular Genetics of Marine Organisms 2003, Vol. 10. Science Publishers Inc., Enfield, New Hampshire. N. Fingerman (Ed.).
27. Martínez-Díaz S.F., Hipólito-Morales A. Efficacy of phage therapy to prevent mortality during the vibriosis of brine shrimp. Aquaculture 2013, 400-401:120-124.
28. Merabishvili M., Pirnay J.-P., Verbeken G., Chanishvili N., Tediashvili M., Lashkhi N., Glonti T., Krylov V., Mast J., Parys L.V., Lavigne R., Volckaer G., Mattheus W., Verween G., Corte P.D., Rose T., Jennes S., Zizi M., Vos D.D., Vaneechoutte M. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE 2009, 4:e4944.
29. Merril C.R., Scholl D., Adhya S. Phage therapy. The Bacteriophage 2006, 725-741. Oxford University Press, New York. R. Calendar (Ed.).
30. Nakai T., Park S.C. Bacteriophage therapy of infectious diseases in aquaculture. Res. Microbiol. 2002, 153:13-18.
31. Nakai T., Sugimoto R., Park K., Matsuoka S., Mori K.-i., Nishioka T., Maruyama K. Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Dis. Aquat. Org. 1999, 37:33-41.
32. Nakai T., Sabour P., Griffiths M. Application of bacteriophages for control of infectious diseases in aquaculture. Bacteriophages in the Control of Food- and Waterborne Pathogens 2010, 257-272. American Society for Microbiology Press, Washington. P.M. Sabour, M.W. Griffiths (Eds.).
33. Noya M., Magarinos B., Lamas J. La administracion intraperitoneal y oral de glucano afecta al sistema immune no especifico ya la resistencia de la dorada, Sparus aurata, a la pasteurelosis. Proceedings of the Fifth National Congress of Aquaculture 1995, 734-738. Sant Carles de la Rapita, Spain.
34. Oliveira J., Castilho F., Cunha A., Pereira M. Bacteriophage therapy as a bacterial control strategy in aquaculture. Aquac. Int. 2012, 20:879-910.
35. Park S., Nakai T. Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis. Dis. Aquat. Org. 2003, 53:33-39.
36. Park S.C., Shimamura I., Fukunaga M., Mori K.-I., Nakai T. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl. Environ. Microbiol. 2000, 66:1416-1422.
37. Pereira C. Use of Bacteriophages on the Inactivation of Pathogenic Bacteria in Aquaculture System 2009, University of Aveiro, Aveiro, Portugal.
38. Pereira C., Silva Y.J., Santos A.L., Gomes N.C.M., Cunha A., Almeida A. Bacteriophages with potential for inactivation of fish pathogenic bacteria: survival, host specificity and effect on bacterial community structure. Mar. Drugs 2011, 9:2236-2255.
39. Sandeep K. Bacteriophage precision drug against bacterial infections. Curr. Sci. 2006, 90:631-633.
40. Scott A.E., Timms A.R., Connerton P.L., Carrillo C.L., Radzum K.A., Connerton I.F. Genome dynamics of Campylobacter jejuni in response to bacteriophage predation. PloS Pathog. 2007, 3:1142-1151.
41. Shivu M.M., Rajeeva B.C., Girisha S.K., Karunasagar I., Krohne G., Karunasagar I. Molecular characterization of Vibrio harveyi bacteriophages isolated from aquaculture environments along the coast of India. Environ. Microbiol. 2007, 9:322-331.
42. Silva Y.J.C., Costa L., Pereira C., Cunha A., Calado R., Gomes N.C.M., Almeida A. Influence of environmental variables in the efficiency of phage therapy in aquaculture. Microb. Biotechnol. 2014, (in press).
43. Silva-Aciares F., Moraga D., Auffret M., Tanguy A., Riquelme C. Transcriptomic and cellular response to bacterial challenge (pathogenic Vibrio parahaemolyticus) in farmed juvenile Haliotis rufescens fed with or without probiotic diet. J. Invertebr. Pathol. 2013, 113:163-176.
44. Skurnik M., Strauch E. Phage therapy: facts and fiction. Int. J. Med. Microbiol. 2006, 296:5-14.
45. Smith H.W., Huggins M. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 1983, 129:2659-2675.
46. Su Y.-C., Liu C. Vibrio parahaemolyticus: a concern of seafood safety. Food Microbiol. 2007, 24:549-558.
47. Sulakvelidze A., Alavidze Z., Morris J.G. Bacteriophage therapy. Antimicrob. Agents Chemother. 2001, 45:649-659.
48. Sung H.-H., Li H.-C., Tsai F.-M., Ting Y.-Y., Chao W.-L. Changes in the composition of Vibrio communities in pond water during tiger shrimp Penaeus monodon cultivation and in the hepatopancreas of healthy and diseased shrimp. J. Exp. Mar. Biol. Ecol. 1999, 236:261-271.
49. Tanji Y., Shimada T., Fukudomi H., Miyanaga K., Nakai Y., Unno H. Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. J. Biosci. Bioeng. 2005, 100:280-287.
50. Thingstad T.F. Elements of a theory for the mechanisms controlling abundance, diversity, and biogeochemical role of lytic bacterial viruses in aquatic systems. Limnol. Oceanogr. 2000, 45:1320-1328.
51. Toranzo A.E., Barreiro S.N., Casal J.F., Figueras A., Magariños B., Barja J.L. Pasteurellosis in cultured gilthead seabream (Sparus aurata): first report in Spain. Aquaculture 1991, 99:1-15.
52. Verner-Jeffreys D.W., Algoet M., Pond M.J., Virdee H.K., Bagwell N.J., Roberts E.G. Furunculosis in Atlantic salmon (Salmo salar L.) is not readily controllable by bacteriophage therapy. Aquaculture 2007, 270:475-484.
53. Vieira A., Silva Y., Cunha A., Gomes N., Ackermann H.-W., Almeida A. Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments. Eur. J. Clin. Microbiol. 2012, 31:3241-3249.
54. Vinod M.G., Shivu M.M., Umesha K.R., Rajeeva B.C., Krohne G., Karunasagar I., Karunasagar I. Isolation of Vibrio harveyi bacteriophage with a potential for biocontrol of luminous vibriosis in hatchery environments. Aquaculture 2006, 255:117-124.
55. Wagner P.L., Waldor M.K. Bacteriophage control of bacterial virulence. Infect. Immun. 2002, 70:3985-3993.